HTRA3
Basic information
Region (hg38): 4:8269754-8307098
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HTRA3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 38 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 1 | 1 |
Variants in HTRA3
This is a list of pathogenic ClinVar variants found in the HTRA3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-8269996-G-C | not specified | Uncertain significance (Mar 19, 2024) | ||
4-8270047-G-T | not specified | Uncertain significance (Jun 03, 2022) | ||
4-8270072-C-G | not specified | Uncertain significance (Apr 06, 2023) | ||
4-8270089-G-A | not specified | Uncertain significance (Jun 28, 2024) | ||
4-8270093-G-T | not specified | Uncertain significance (Oct 12, 2022) | ||
4-8270150-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
4-8270155-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
4-8270179-G-T | not specified | Uncertain significance (Mar 07, 2023) | ||
4-8270230-G-A | not specified | Uncertain significance (Jan 24, 2023) | ||
4-8270294-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
4-8270311-G-A | not specified | Uncertain significance (Sep 07, 2022) | ||
4-8270329-C-A | not specified | Uncertain significance (Mar 30, 2024) | ||
4-8282461-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
4-8286566-C-T | not specified | Uncertain significance (Sep 26, 2024) | ||
4-8286583-G-A | not specified | Uncertain significance (Sep 08, 2024) | ||
4-8286598-G-A | not specified | Uncertain significance (Jun 02, 2024) | ||
4-8286626-G-A | not specified | Uncertain significance (Jun 05, 2024) | ||
4-8286660-C-G | not specified | Uncertain significance (Sep 02, 2024) | ||
4-8286672-C-T | Likely benign (Nov 01, 2024) | |||
4-8286674-C-A | not specified | Uncertain significance (Jun 05, 2023) | ||
4-8286674-C-T | not specified | Uncertain significance (Feb 25, 2025) | ||
4-8286712-G-T | not specified | Uncertain significance (Jan 19, 2025) | ||
4-8286715-T-G | not specified | Uncertain significance (Sep 16, 2021) | ||
4-8286739-A-G | not specified | Uncertain significance (Aug 12, 2024) | ||
4-8286766-A-G | not specified | Uncertain significance (Mar 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HTRA3 | protein_coding | protein_coding | ENST00000307358 | 9 | 37347 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.58e-8 | 0.454 | 125712 | 0 | 35 | 125747 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.496 | 243 | 266 | 0.914 | 0.0000169 | 2874 |
Missense in Polyphen | 93 | 115.36 | 0.80614 | 1129 | ||
Synonymous | -0.178 | 124 | 122 | 1.02 | 0.00000851 | 960 |
Loss of Function | 0.853 | 13 | 16.8 | 0.775 | 7.93e-7 | 203 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000297 | 0.000297 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000977 | 0.0000967 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000335 | 0.000327 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Serine protease that cleaves beta-casein/CSN2 as well as several extracellular matrix (ECM) proteoglycans such as decorin/DCN, biglycan/BGN and fibronectin/FN1. Inhibits signaling mediated by TGF-beta family proteins possibly indirectly by degradation of these ECM proteoglycans (By similarity). May act as a tumor suppressor. Negatively regulates, in vitro, trophoblast invasion during placental development and may be involved in the development of the placenta in vivo. May also have a role in ovarian development, granulosa cell differentiation and luteinization (PubMed:21321049, PubMed:22229724). {ECO:0000250|UniProtKB:Q9D236, ECO:0000269|PubMed:21321049, ECO:0000269|PubMed:22229724}.;
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.279
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.77
Haploinsufficiency Scores
- pHI
- 0.162
- hipred
- N
- hipred_score
- 0.276
- ghis
- 0.509
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.362
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Htra3
- Phenotype
Gene ontology
- Biological process
- regulation of cell growth;proteolysis;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway
- Cellular component
- extracellular region
- Molecular function
- endopeptidase activity;serine-type endopeptidase activity;protein binding;insulin-like growth factor binding;serine-type peptidase activity